Ct Methylphenidate Er (2020-02-07)
ACT Methylphenidate ER Recall Summary ACT Methylphenidate ER tablets are being recalled across Canada due to a product safety issue. Methylphenidate is a medication used to treat attention deficit hyperactivity disorder (ADHD). This recall affects all customers who have this medication.
- Reason
- Product safety
- Classification
- Class I
- Category
- drug recall
- Country
- Canada
- Agency
- HC-DRUGS
- Recall date
- 2020-02-07
- Status
- Ongoing
- Distribution
- Canada-wide
Official recall notice from HC-DRUGS
Recall details on Nibble Recalls: https://trynibble.app/recalls/9c4a4e93-adb5-4be2-b263-e7fc92869333